Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prostate Specific Antigen and Gleason Score in Men with Prostate Cancer at a Private Diagnostic Radiology Centre in Western Jamaica

  • Anderson-Jackson, Lennox (Radiology West) ;
  • McGrowder, Donovan A. (Department of Pathology, Faculty of Medical Sciences, The University of the West Indies) ;
  • Alexander-Lindo, Ruby (Department of Basic Medical Sciences (Biochemistry Section), Faculty of Medical Sciences, The University of the West Indies)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Prostate cancer is the most common malignant tumour in men and the second most common cause of male cancer death. The study examines the clinicopathological features of patients with prostate cancer consecutively diagnosed at a private Diagnostic Radiology Centre in Western Jamaica over a 6-year period. Method: The medical records, including the pathology reports of 423 consecutive patients who had transrectal ultrasonography (TRUS) - guided prostate biopsy between January 2006 and December 2011 were reviewed. Results: The mean age at diagnosis of the 191 men with prostate adenocarcinoma was $68.5{\pm}0.59$ years with the majority in the 70 - 79 year age group (43.5%). Moderately differentiated carcinomas (Gleason score of 6) comprised the largest group with 72 cases (37.9%); poorly differentiated cancers with Gleason scores of 8 - 10 comprised 49 cases (25.8%). The PSA levels increased with Gleason score. The mean PSA levels for men with Gleason score of 6 was $50.1{\pm}30.0$ ng/mL compared with $136.5 {\pm}59.9$ ng/mL in patients with Gleason score of 8 and $140.5{\pm}31.8$ ng/mL in patients with Gleason score of 9. Perineural invasion was present in 7.85% of the cases overall; high-grade prostatic intraepithelial neoplasia (HGPIN) was present in 4.71% of the biopsies. Conclusion: Although the majority of patients had moderate, and moderate to poor differentiated carcinomas, the number with poorly differentiated carcinoma was high. This is a reflection of the patients' late clinical presentation at the time of diagnosis.

Keywords

References

  1. Aihara M, Lebovitz RM, Wheeler TM, et al (1994). Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer. J Urol, 151, 1558-64.
  2. American Cancer Society. Cancer Facts and Figures (1998), New York: American Cancer Society.
  3. Aprikian AG, Zhang ZF, Fair WR (1994). Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients. Cancer, 74, 1768-77. https://doi.org/10.1002/1097-0142(19940915)74:6<1768::AID-CNCR2820740620>3.0.CO;2-9
  4. Blake G, Hanchard B, Mitchell K, et al (2002). Jamaica cancer mortality statistics, 1999. West Indian Med J, 51, 64-7.
  5. Bunker CH, Patrick AL, Konety, BR (2002). High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago prostate cancer survey, Cancer Epidemiol Biomarkers & Prev, 8, 726-9.
  6. Coard KC, Skeete DH (2008). A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica. BJU Int, 103, 1482-6.
  7. D'Amico AV, Wu Y, Chen MH, et al (2001). Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol, 165, 126-9. https://doi.org/10.1097/00005392-200101000-00031
  8. Farkas A, Schneider D, Perrotti M, et al (1998). National trends in the epidemiology of prostate cancer, 1973-94: evidence for the effectiveness of prostate-specific antigen screening. J Urol, 52, 444-8. https://doi.org/10.1016/S0090-4295(98)00242-8
  9. Gibson T, Blake G, Hanchard B, et al (2008). Age-specific incidence of cancer in Kingston and St. Andrew, 1998-2002. West Indian Med J, 57, 81-9.
  10. Gibson TN, Hanchard B, Waugh N, et al (2010). Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003-2007. West Indian Med J, 59, 456-64.
  11. Gleason DF (1992). Histologic grading of prostate cancer: A perspective. Hum Pathol, 23, 273-9. https://doi.org/10.1016/0046-8177(92)90108-F
  12. Gugliotta A, Ferreira U, Reis LO, et al (2008). Satisfaction analysis in men presenting with localized prostate cancer treated with radical prostatectomy or radiotherapy: psychological and social aspects. Actas Urol Esp, 32, 411-6. https://doi.org/10.1016/S0210-4806(08)73855-5
  13. Hanchard B, Blake G, Wolff C, et al (2001). Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 1993 - 1997. West Indian Med J, 50, 123-9.
  14. Jemal A, Siegel R,Ward E, et al (2008). Cancer statistics, 2008, CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  15. Low W, Bergstralh EJ, Blute ML, et al (2002). Radical prostate cancer: Influence of concomitant pathological variables. J Urol, 167, 117-22. https://doi.org/10.1016/S0022-5347(05)65394-3
  16. Partin AW, Carter HB, Chan DW, et al (1990). Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol, 143, 747-52.
  17. Ravery V, Javerliat I, Toublanc M, et al (2000). Features of prostatic cancer in French individuals of African-Caribbean origin. Prog Urol, 10, 231-6.
  18. Reis LO, Sasse AD, Matheus WE, et al (2009). Prostate cancer: evidence based clinical practice. Actas Urol Esp, 33, 344-50. https://doi.org/10.1016/S0210-4806(09)74158-0
  19. Roehl AK, Antenor AJ, Catalona JW (2002). Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng/mL range. J Urol, 168, 922-5. https://doi.org/10.1016/S0022-5347(05)64543-0
  20. Shirley SE, Escoffery CT, Sargeant LA, et al (2002). Clinicopathological features of prostate cancer in Jamaican men. BJU Int, 89, 390-5. https://doi.org/10.1046/j.1464-4096.2001.01871.x
  21. Vargas SO, Jiroutek M, Welch WR, et al (1999). Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol. 111, 223-8.

Cited by

  1. Histopathologic Characterization of Prostate Diseases in Madinah, Saudi Arabia vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4175
  2. Frequency of Unnecessarily Biopsies among Patients with Suspicion of Prostate Cancer in Syrian Men vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5967
  3. Rural and Urban Differences in Stage at Diagnosis of Prostate Cancer in Hunan Province, China vol.26, pp.3, 2018, https://doi.org/10.1177/1054137316654270